Tag Archive | "Allergan"

Big pharma, Valeant bids for a merger with Allergan

Tags: , , ,


Big Pharma, Valeant Pharmaceuticals International Team Up To Make $45.6 Billion Allergan Bid. Read the full story

Allergan, the big pharma, sells its obesity intervention division for $110 million

Tags: , , , ,


Apollo Endosurgery has entered into a definitive agreement to purchase the obesity intervention division of the big pharma, Allergan for up to $110 million.

Read the full story

InnoCore in pharma licensing pact with Allergan

Tags: , , ,


InnoCore Pharmaceuticals has signed an exclusive pharma Licensing and Collaboration Agreement with Allergan, a big pharma company. Read the full story

Allergan and Medytox close pharma licensing deal for $362 million

Tags: , , ,


Allergan, a big pharma company, and Medytox have entered into a pharma licensing agreement pursuant to which, upon closing, Allergan will pay Medytox an upfront payment of U.S. $65 million and Medytox will grant Allergan exclusive rights, worldwide outside of Korea, to develop and Read the full story

Partnering with Allergan: Looking for partnerships and a higher bidder

Tags: , ,


Allergan is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter consumer products worldwide. Read the full story

Allergan: Partnering activity 2005-2013

Tags: , ,


Allergan announced over 70 partnering / licensing deals since 2005 Read the full story

Allergan: M&A activity 2005-2013

Tags: ,


Allergan has also announced 11 M&A deals since 2005, with the lead deals being the merger of Inamed Corp in 2005 and MAP Pharmaceuticals in 2013 Read the full story

Will Allergan and Forest bid for Elan?

Tags: , , , ,


Sources suggest that Allergan and Forest will table rival bids to acquire Elan this week Read the full story

Allergan stock slide makes company an acquisition target

Tags: , ,


Allergan’s market value has tumbled to $25 billion as investors became concerned that generic competition to its Restasis eye drops and delayed drug studies would crimp future sales growth Read the full story

Allergan looks to sell lap-band and obesity unit

Tags: , ,


Allergan, one of the top 50 big pharma companies, is committed to selling the company’s obesity-treatment unit in the first half of 2013 after completing a review of the business. Read the full story